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Age-related hearing loss (presbycusis) is a significant problem in the population. The genetic contribution to age-
related hearing loss is estimated to be 40%–50%. Gene mutations that cause nonsyndromic progressive hearing
loss with early onset may provide insight into the etiology of presbycusis. We have identified four families segregating
an autosomal dominant, progressive, sensorineural hearing loss phenotype that has been linked to chromosome
17q25.3. The critical interval containing the causative gene was narrowed to ∼2 million bp between markers
D17S914 and D17S668. Cochlear-expressed genes were sequenced in affected family members. Sequence analysis
of the g-actin gene (ACTG1) revealed missense mutations in highly conserved actin domains in all four families.
These mutations change amino acids that are conserved in all actins, from protozoa to mammals, and were not
found in 1100 chromosomes from normal hearing individuals. Much of the specialized ultrastructural organization
of the cells in the cochlea is based on the actin cytoskeleton. Many of the mutations known to cause either syndromic
or nonsyndromic deafness occur in genes that interact with actin (e.g., the myosins, espin, and harmonin). The
mutations we have identified are in various binding domains of actin and are predicted to mildly interfere with
bundling, gelation, polymerization, or myosin movement and may cause hearing loss by hindering the repair or
stability of cochlear cell structures damaged by noise or aging. This is the first description of a mutation in
cytoskeletal, or nonmuscle, actin.
Introduction
Twenty-eight million Americans suffer from hearing im-
pairment, including half of all octogenarians (Morton
1991). Although some degree of age-related hearing loss
(ARHL, presbycusis) must be ascribed to environmental
exposures, it is clear that a significant fraction—perhaps
as much as 50%—is genetically determined (Karlsson et
al. 1997; Gates et al. 1999; DeStefano et al. 2003). Coch-
lear pathologies associated with ARHL include degen-
eration of hair cells, neuronal loss, and atrophy of the
stria vascularis (Fransen et al. 2003). Clinical correlates
of these pathologies have been proposed, with sensory
presbycusis—the most common type of ARHL—being
defined as an elevation of high frequency pure-tone
thresholds secondary to loss of hair cells at the basal
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end of the cochlea (Schuknecht and Gacek 1993). This
region is especially vulnerable to damage by noise and
aging, both of which are likely to be important com-
ponents of ARHL (Fransen et al. 2003). To understand
the etiology of ARHL, the physiology of hearing and
the pathology of hearing loss must be understood at the
molecular level. This imperative makes genes associated
with late-onset nonsyndromic deafness excellent candi-
dates for involvement in ARHL. The phenotype and pro-
gression of hearing loss are similar; only the age at onset
differs (Steel 1998).
Much of the function of the inner ear relies on the
specialized structure of the auditory hair cell. These
structures are highly dependent on their actin cytoske-
letons (Hofer et al. 1997). In the apical region of the
hair cell, the projecting stereocilia contain parallel bun-
dles of actin fibers with identical polarity (Tilney et al.
1983); in the cuticular plate immediately below the api-
cal surface, a dense gel-like network of actin filaments
anchors the stereocilia (DeRosier and Tilney 1989), and
encircling the hair cell near the apical region is the ad-
herens junction, which contains antiparallel actin fila-
ments (Hirokawa and Tilney 1982). The basolateral re-
gion of the hair cell also contains actin structures that
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support the cell membrane and provide a track for the
passage of synaptic vesicles.
The predominant actin isoform in the auditory hair
cell is g-actin, encoded by ACTG1 (MIM 102560), one
of six functional actin genes in humans. Four actin genes
encode isoforms responsible for contractile movement in
muscle. The remaining actin genes, ACTG1 and ACTB,
code for proteins found in the cytoskeleton of all mam-
malian cells and differ from each other by only four
amino acids at or near the N-terminus. b-Actin is the
predominant isoform in most cells, although g-actin pre-
dominates in intestinal epithelial cells as well as in au-
ditory hair cells, where it is found in stereocilia, the cu-
ticular plate, and adherens junctions (Khaitlina 2001). It
is notable that actin structures appear to be structurally
damaged as a consequence of noise exposure and aging
(Li and Hultcrantz 1994; Hultcrantz and Li 1995; Hu
and Henderson 1997).
DFNA20 (MIM 604717) and DFNA26 (MIM
604717) are dominant nonsyndromic deafness loci that
map to the telomeric region of the long arm of chro-
mosome 17 (Morell et al. 2000; Yang and Smith 2000).
Persons affected with the DFNA20 and DFNA26
(DFNA20/26) disorders display sensorineural hearing
loss that, like ARHL, begins in the high frequencies and
steadily progresses to include all frequencies (Yang and
Smith 2000; Elfenbein et al. 2001). Distortion product
otoacoustic emission (DPOAE) data are consistent with
a cochlear site of lesion (Elfenbein et al. 2001). We have
determined that mutations in g-actin are the basis for
hearing loss in four families affected with DFNA20/26.
Methods
Subjects
Family MSUDF1.—Family MSUDF1 was ascertained
through the Michigan State University (MSU) Genetics
Clinic. Physical examination of the proband by a clinical
geneticist included examination for features associated
with syndromic hearing losses. An additional neurolog-
ical exam provided no evidence for vestibular dysfunc-
tion. Audiologic examination of family members in-
cluded otoscopy, tympanometry, and pure-tone and air-
and bone-conduction thresholds. DPOAE and speech-
recognition data were collected from a subset of persons.
Individuals aged 25 years were considered affected if
they had bilateral sloping sensorineural hearing loss in
the high frequencies beyond the 90th percentile of an
age- and sex-dependent curve of the general population
(International Organization for Standardization 1984;
Cruickshanks et al. 1998). The proband’s 72-year-old
spouse, who had a history of noise exposure, showed
this pattern but demonstrated hearing within normal
limits in the low frequencies. He was considered unaf-
fected. Information on deceased family members was
obtained from relatives and census data. Written in-
formed consent for all procedures and investigations was
obtained according to the research protocol approved
by the MSU Institutional Review Board.
Families 1250 and 1320.—Families 1250 and 1320
were ascertained through the Department of Otolaryn-
gology–Head and Neck Surgery at the University of
Iowa. Family histories were obtained by questionnaire
and personal interviews. Information on deceased family
members was obtained from relatives. Otologic exami-
nation and audiograms were performed or reviewed on
most family members. Individuals were considered af-
fected if they had bilateral sensorineural hearing loss in
the high frequencies below the 95th percentile of an age-
and sex-dependent control curve of the general popu-
lation. Normal-hearing individuals 120 years of age
were coded as unaffected if hearing thresholds at most
frequencies were better than 20 dB hearing level or were
above the 50th percentile. Peripheral venous blood was
collected by venipuncture from consenting individuals.
All procedures complied with accepted protocols from
the Institutional Review Board at the University of Iowa.
Kindred 6.—Kindred 6 was ascertained at The Rock-
efeller University. A family history was obtained through
questionnaires and oral interview. Pure-tone audiometry
(air and bone conduction), a medical history and DNA
samples were obtained from pedigree members in three
generations. Hearing-impaired family members 35
years of age presented with moderate-to-severe hearing
loss in the low frequencies, which sloped to profound
hearing loss in the middle-to-high frequencies. Younger
hearing-impaired family members presented with nor-
mal hearing in the low frequencies, mild-to-moderate
hearing loss in the middle frequencies, and moderate-to-
severe hearing loss in the high frequencies. Average age
at onset was 13.2 years (SD 4.6 years). The deafness
locus segregating in this pedigree linked to markers lo-
cated on 17q25.3, with a maximum two-point LOD
score of 6.3 (DeWan et al. 2003). Informed consent for
all procedures was obtained according to the research
protocol that was approved by The Rockefeller Univer-
sity Institutional Review Board.
DNA Sequencing and Mutation Detection
Generation of somatic cell hybrids.—To efficiently
screen candidate genes by sequence analysis, human-
mouse somatic hybrid cell lines were used. A whole
blood sample from the MSUDF1 proband was supplied
to GMP Genetics for establishment of somatic hybrid
cell lines containing single copies of human chromosome
17. Three cell lines were obtained, one of which con-
tained the chromosome 17 that bears the haplotype of
the critical region containing the DFNA20 locus. These
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cell lines were used to generate cDNA for RT-PCR se-
quencing of large genes that had !90% identity with
mouse sequences to avoid coamplification of mouse
cDNA.
g-Actin mutation identification.—PCR primers synthe-
sized in the MSU Genomic Technology Support Facility
(GTSF) were used for amplification of human g-actin ex-
ons and flanking intron sequences, as follows: exon 1,
GA1453 (5′-gctttcggaaagatcgccat-3′) and GA1454 (5′-tac-
gtaacgtccacggctcg-3′), 390 bp; exons 2–3, GA1455 (5′-
gttgcgatcttggaggccac-3′) and GA1456 (5′-acagagcctggaac-
agcgaa-3′), 698 bp; exons 4–5, GA1457 (5′-cactggcatgcag-
catgttg-3′) and GA1458 (5′-gcacggcttcagctcgcaga-3′), 864
bp; exon 6 and 3′ UTR, either GA1459 (5′-ctctgcgagctgaa-
gccgtg-3′) and GA1460 (5′-cgaagccaagctgagcagca-3′),
1,014 bp, or GAA04 (5′-tgaggctagcatgaggtgtg-3′, 270 bp,
paired with GA1459. PCR amplification was performed
under standard conditions, by use of Taq DNA poly-
merase (QIAGEN) with 60C annealing temperature. Fol-
lowing amplification, the PCR products were pooled from
three identical reactions and were purified using QIAquick
PCR Purification Kit (QIAGEN). Purified PCR products
were sequenced using the ABI Prism BigDye terminator
and were analyzed on an ABI Prism 3100 Genetic Ana-
lyzer (PE Applied Biosystems) and ABI 3730 Genetic XL
DNA Analyzer or ABI Prism 3700 DNA Analyzer in the
GTSF. DNA sequences were analyzed using the Se-
quencher software (Gene Code Corporation).
g-Actin mutation detection in control samples.—To
evaluate whether the sequence variations we identified
occurred in the normal hearing population, we se-
quenced g-actin in unrelated individuals who had been
tested and found to have normal hearing for their age.
These control samples are whites and ethnically match
our families, all of which are North American and of
Western European descent. For the control samples, 5-
ml PCRs were treated with 1 U of shrimp alkaline phos-
phatase and 10 U of exonuclease I (USB) at 37C for 15
min and 80C for 15 min and were sequenced and an-
alyzed following the same procedures described earlier.
For mutation T89I and K118M, exons 2–3 were am-
plified in 110 individuals by use of the primer pairs de-
scribed above and were sequenced using forward prim-
ers. For P264L and P332A, primers GA1457/58 and
GA1459/GAA04, respectively, were used to amplify ge-
nomic DNA from 51 individuals.
Results
DFNA20/26 Critical Interval Determination
The DFNA20 locus originally was assigned to chro-
mosome 17q25.3 between markers D17S1806 and
D17S668 (Morell et al. 2000). The MSUDF1 family (fig.
1) contained a 21-year-old member with normal hearing
who carried a recombination within this interval. Two
years later, this subject’s hearing was still well within
normal limits. Since all affected family members had
clear signs of hearing loss by this age (Elfenbein et al.
2001), this subject was considered unaffected, which al-
lowed us to refine the centromeric boundary of the
DFNA20 critical interval to 50 kb telomeric to marker
D17S914. The telomeric boundary remained unchan-
ged, thereby defining a 5.3-cM region of ∼2 # 106 bp.
Two families segregating autosomal dominant non-
syndromic deafness have been mapped to a region over-
lapping the DFNA20 interval and have been given a
DFNA26 designation (families 1250 and 1320 in fig. 1)
(Yang and Smith 2000). Although these were large fam-
ilies, they defined a critical interval that was still 16 #
106 bp. Most recently, linkage in an additional family
has been described that encompasses the same critical
interval as DFNA20 (kindred 6 in fig. 1) (DeWan et al.
2003). The gene for Usher syndrome 1G and the Jackson
shaker mouse mutant localizes ∼6# 106 bp centromeric
to the DFNA20 critical interval and has been identified
as SANS (Kikkawa et al. 2003; Weil et al. 2003).
Phenotype of Hearing Loss
All families with DFNA20/26 display progressive, bi-
lateral, sensorineural hearing loss that begins in the high
frequencies. As age increases, the degree of hearing loss
increases, with threshold shifts seen at all frequencies,
although a sloping configuration is usually maintained.
Age at onset varies between families, with self-reported
hearing loss noticed in the 3rd decade in MSUDF1 but
beginning in the 2nd decade in families 1250 and 1320
and in kindred 6 (fig. 1). Hearing threshold shifts are
detectable beginning in the early teens in MSUDF1 and
earlier in family 1250 and kindred 6. In families 1250
and 1320, by the 6th decade, progression of hearing loss
leads to profound deafness across all frequencies. Mem-
bers of both of these families have cochlear implants. In
contrast, the proband in MSUDF1, at 65 years of age,
had profound loss at 11000 Hz but retained thresholds
at 60–80 dB in the lower frequencies.
There is no evidence of vestibular dysfunction in any
persons in these families, by self-report or by testing in
MSUDF1 (Elfenbein et al. 2001). Questionnaires have
not revealed any additional physical problems and no
abnormalities of stature, hands, or craniofacial struc-
tures have been observed. Lifespan appears normal.
Genes in the Critical Interval
The DFNA20/26 critical interval between markers
D17S914 and D17S688 contains few genes with known
function. Multiple builds of the Human Genome Project
produced incomplete contigs across the interval. Even-
tually, ∼20 genes were identified in the region; most of
these were hypothetical proteins with no documented
functions. Not all of the expressed UniGene sequences
Figure 1 Families with autosomal dominant hearing loss linked to chromosome 17q25. Left, pedigrees of four families segregating highly
penetrant autosomal dominant, sensorineural, postlingual hearing loss. Asterisks (*) indicate the persons in each pedigree who received au-
diological testing. The 21-year-old recombinant in family MSUDF1 who allowed refinement of the critical interval is indicated by an unfilled
arrow; probands are indicated by filled arrows. Right, threshold data from the better ears of representative patients. Ages at testing are noted
to the right of the audiograms. The individuals used to provide the graphic data are denoted by a star in families 1250 and 1320 and by their
ages in family MSUDF1 and kindred 6.
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were identified as RefSeq genes and not all of the genes
were complete. Many of these genes were examined for
expression in the inner ear, either by testing of STS mark-
ers on a human cochlear cDNA library (a gift from James
Battey and Lori Hampton, National Institute on Deaf-
ness and Other Communication Disorders) or by search-
ing the Inner Ear Gene Expression Database for the hom-
olog in the mouse. Genes that showed expression in the
cochlea or that contained domains that suggested coch-
lea-related functions were sequenced. There were a sub-
stantial number of genes that could be considered strong
candidates.
For sequencing of genes in family MSUDF1, conversion
cell hybrids were generated (GMP Genetics) that pro-
duced mouse cell lines, each carrying a single chromosome
17 from the proband. Sequencing was then carried out
by PCR amplification of genomic DNA, cDNA from the
hybrid cell lines, or genomic DNA from an affected in-
dividual in the family. Genes with large mRNAs and
!90% human/mouse identity were sequenced from RT-
PCR products. Genes sequenced in MSUDF1 included:
MGC46523 (SLC26A11 solute transporter, similar to
Pendrin), KIAA1554 (probable thromboxane A2 receptor
isoform), KIAA1303 (raptor, G protein with WD repeats),
KIAA1118 (mouse acrosomal protein AZ1 homology,
ERM domain, collagen homology domain), FLJ31528
(hypothetical protein, mouse homolog has inner ear ex-
pression), MGC15523 (transporter protein domain, in-
tegrin domain, strong inner ear expression), KIAA1447
(collagen homology domain), FLJ23058 (no known pro-
tein homologies, strong ear expression, multiple tissues),
PDE6G (phosphodiesterase 6 G-retinal specific),
MRPL12 (mitochondrial ribosomal protein L12), and
SLC25A10 (mitochondrial solute carrier, dicarboxylate
transporter). Differences from the reference sequence
were evaluated for likelihood to affect protein synthesis
or function, for conservation between species, and for
segregation with hearing loss. Many of the genes con-
tained polymorphisms that were found in multiple fam-
ily members, both affected and nonaffected.
Numerous genes in the region flanked by D17S784 and
D17S928 were screened for mutations in families 1250
and 1320. The list included CBX4, FLJ20753, GAA,
KIAA0111, CARD14, SGSH, KIAA1554, NPTX1,
Raptor, BAIAP2, AATK, KIAA1118, FLJ31528,
MGC15523, HGS, MRPL12, SLC25A10, SECTM1,
SLC16A3, and CSNK1D.
g-Actin
Because the telomeric region of mouse chromosome
11 has homologous synteny with human chromosome
17, we were able to place several additional genes in the
DFNA20/26 critical region by inspection of mouse ge-
nome data. The most interesting genes were Fscn2
(which encodes an actin bundling protein) and Actg (g-
actin). Sequencing of human FSCN2 yielded an intron
polymorphism that we used to place this gene within
the critical interval in MSUDF1. Actin was sequenced
from genomic DNA from the hybrid cell line and from
an affected individual (fig. 2), and nine differences from
the reference sequence were found. When Genbank ac-
cession #M19238 was used as the reference sequence,
differences included one in the 5′ transcribed noncoding
region (494, GrA), six in introns (C677T, G833T,
C1386A, G1432A, G1433T, and T2122A), and a syn-
onymous change in the stop codon (TAGrTAA). None
of these variations was predicted to affect function of
g-actin, and they were also found in unaffected family
members and the controls. Three variants—G833T,
T2122A, and TAGrTAA—were also found in reference
sequence AC139149. The only sequence change unique
to all 17 affected family members was the CrT tran-
sition at nucleotide 340 in exon 3 of the processed
mRNA, which produces a nonconservative amino acid
substitution, T89I. This amino acid is perfectly con-
served in cytoplasmic actin, in species ranging from nem-
atodes to mammals (fig. 3). In skeletal muscle actin,
serine can replace threonine at this position. In com-
parison with 141 unique actin sequences from species
including fungi, plants, protozoa, invertebrate, and ver-
tebrates, this position is occupied by a hydroxyl-con-
taining amino acid (Sheterline et al. 1998). This mu-
tation was not found in 220 chromosomes from
individuals with documented normal hearing.
Sequence analysis of actin from families 1250 and
1320 (Yang and Smith 2000) also revealed mutations in
g-actin. A lysine-to-methionine change was found at
amino acid 118 in family 1250. The mutation segregated
with hearing loss in this family (eight affected family
members) and was not found in 220 chromosomes from
normal hearing individuals. The amino acid in this po-
sition of actin is invariant in vertebrates and inverte-
brates and is replaced by arginine in a few species of
plants and fungi. In family 1320, a proline-to-alanine
substitution segregating with hearing loss was identified
in amino acid 332. This amino acid is invariant in cy-
toplasmic actin (fig. 3), and, out of 141 actin sequences,
it is replaced by serine in only 1 species (a protozoan).
This mutation was found in the eight affected family
members tested, and no change in this amino acid was
found in 102 chromosomes from individuals with nor-
mal hearing.
Kindred 6 (DeWan et al. 2003) carries a proline-to-
leucine mutation at amino acid 264 (fig. 2). This amino
acid is perfectly conserved in the g-actin isoforms (fig.
3), is invariant in 138/141 actin sequences, and is never
leucine (Sheterline et al. 1998). The mutation cosegre-
gates with hearing loss in 11 persons from kindred 6
and in a 20-year-old individual who carries this mutation
Figure 2 g-Actin mutation analyses. A, Genomic structure of g-actin showing the mature mRNA sequence in large blocks. There is a 5′
noncoding exon and a substantial 3′ UTR. The position of the mutations is identified with a down-pointing arrow (f), and the primers used
for sequencing are indicated. B, Sequence results for each of the mutations. Each mutation is heterozygous in affected individuals. C, Structural
model of actin (Kabsch et al. 1990) showing the positions of the amino acids that are altered in families with DFNA20/26.
1088 Am. J. Hum. Genet. 73:1082–1091, 2003
Figure 3 Conservation of actin proteins. MultAlin view of cytoplasmic actin molecules from various species. The top five sequences are
g-actin from human, mouse, bovine, frog, and rabbit, respectively, followed by chicken and goldfish b-actin, shrimp actin, fruitfly actin 5c,
silkworm actin A4, and nematode actin. Human b-actin differs from g-actin in that it carries an E at the N-terminal positions marked with
asterisks (*) and a V at the position marked with a number sign (#).
but may be too young to show signs of hearing loss.
The mutation was not found in 102 chromosomes from
normal hearing individuals.
Discussion
g-Actin Mutations Are Associated with Hearing Loss
DFNA20/26 hearing loss is associated with missense
mutations in ACTG1. Actin is one of the most highly
conserved proteins known, with 190% homology be-
tween the single yeast actin (ACT1) gene and human g-
actin. Vertebrate g-actin proteins are identical in hu-
mans, mice, cattle, and chickens (Sheterline 1998). Until
now, no mutations in vertebrate nonmuscle actins have
been identified. De novo and familial mutations in heart
muscle actin, ACTC, have been reported to cause dilated
cardiomyopathy (Olson et al. 1998) and hypertrophic
cardiomyopathy (Olson et al. 2000), whereas mutations
in a-actin can cause nemaline myopathy (Ilkovski et al.
2001). Mutations that change the amino acid structure
of actin are generally not tolerated, because actin has a
remarkable number of interacting ligands and protein
partners that bind noncovalently with actin to produce
movement, support cellular structures, and regulate cel-
lular responses.
We have identified four families with mutations in
ACTG1. In these families, the only phenotype is pro-
gressive hearing loss. No other physical symptoms have
been observed, and lifespan appears normal. There are,
however, differences between families in average age at
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onset of hearing loss and rate of progression. The four
different ACTG1 mutations occur in three of the four
subdomains of the g-actin protein (fig. 2c).
Two of the mutations, T89I and K118M, occur in
subdomain 1. The T89I mutation is in an alpha helix
that is thought to participate in binding of fimbrin, a
bundling protein. An identical mutation in ACT1 in
yeast has been identified as a suppressor of a mutation
of SAC6 (yeast fimbrin) (Adams et al. 1989; Honts et
al. 1994). The T89I mutation in ACT1 produced a mild
temperature-sensitive phenotype in yeast (Adams et al.
1989). K118M is near the fimbrin-binding domain that
has been implicated in interactions with fimbrin, gelsolin
(Feinberg et al. 1997), and a-actinin (Fabbrizio et al.
1993; McGough et al. 1994). In the families segregating
these mutations, the hearing loss is dissimilar, with fam-
ily 1250 segregating a more severe phenotype that is
characterized by an earlier age at onset and more rapid
progression (fig. 1).
P264L is in a proposed hydrophobic plug for inter-
strand interactions in subdomain 4, very near the actin
self-assembly site. It is not known whether this amino
acid is required for actin filament assembly. The family
carrying this mutation has an early age at onset of hear-
ing loss that progresses rapidly to profound levels at the
higher frequencies.
The actin mutation found in family 1320, P332A, is
in a 3–amino acid loop in subdomain 3 of the actin
protein (Khaitlina 2001). There is evidence that this loop
is part of the primary contact site for myosin (Fabbrizio
et al. 1993). The hearing loss in this family is similar to
the hearing loss in family 1250 and in kindred 6 (fig.
1).
Role of Actin in Maintaining Cochlear Structure
Of the two isoforms of actin in nonmuscle cells, b-
actin generally predominates. Only in intestinal cells and
auditory hair cells is g-actin more abundant (Khaitlina
2001). In tissues in which cells are frequently replaced,
such as the intestinal epithelium, it is possible that the
effects of these actin mutations have little consequence.
However, in the cochlear hair cells, which do not re-
generate, the long-term effect of subtle actin mutations
may have a particular impact. In auditory hair cells, g-
actin is found in all actin-containing structures, includ-
ing the cuticular plate, adherens junction, and the ster-
eocilia (Hofer et al. 1997); b-actin is primarily restricted
to the stereocilia (Schneider et al. 2002). The importance
of actin to hair cell function is reflected by the fact that
mutations in many of the actin-interacting proteins cause
hearing loss. Included in this list are mutations in several
of the unconventional myosins, espin, and harmonin
that can lead to various types of dominant and recessive
syndromic and nonsyndromic deafness (Petit et al. 2001;
Anagnostopoulos 2002; Boeda et al. 2002; Zuo 2002).
Hair cells in mammals do not regenerate and conse-
quently must withstand a lifetime of use and misuse. It
is likely that actin and actin-interacting proteins play an
important role in maintaining these cells and in repairing
damage. Not unexpectedly, aging and noise damage
have profound effects on the structure of the hair cells.
Mice with ARHL have cochlear changes that involve
actin (Hultcrantz and Li 1995; Hu et al. 2002), and
humans with presbycusis show hair-cell degeneration or
loss (Soucek et al. 1987). Noise-induced hair-cell damage
results in scar formation necessary to retain the integrity
of the reticular lamina, a process that is likely to involve
the actin-myosin system (Raphael 2002) very early in
the apoptotic cascade.
The mutations we have identified in families with
DFNA20/26 occur in various binding domains of actin
and are predicted to mildly interfere with bundling, ge-
lation, polymerization, or myosin movement. As such,
they may produce hearing loss by reducing the stability
of these cochlear cell structures or by impeding the repair
of structures damaged by noise or aging. Given the cen-
tral role of actin in the function of the inner ear, it might
not be surprising that mutations in ACTG1 may cause
deafness. The unanticipated aspect of our finding is that
mutations can be found at all in this remarkably evo-
lutionarily conserved protein and that it is possible to
have mutations in this ubiquitously expressed gene that
are associated only with nonsyndromic deafness. This
finding may be a reflection of the fact that the cells of
the organ of Corti are different from other ACTG1-
expressing cells in the amount of mechanical trauma to
which they are subjected and the fact that, as mechanical
transducers of sound, their function is highly dependent
on precise control of their form.
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